Maxigen Biotech Inc
TWSE:1783

Watchlist Manager
Maxigen Biotech Inc Logo
Maxigen Biotech Inc
TWSE:1783
Watchlist
Price: 41.9 TWD 0.12% Market Closed
Market Cap: 3.7B TWD
Have any thoughts about
Maxigen Biotech Inc?
Write Note

Maxigen Biotech Inc
Additional Paid In Capital

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Maxigen Biotech Inc
Additional Paid In Capital Peer Comparison

Comparables:
G
1707
1731
4137

Competitive Additional Paid In Capital Analysis
Latest Figures & CAGR of Competitors

Company Additional Paid In Capital CAGR 3Y CAGR 5Y CAGR 10Y
Maxigen Biotech Inc
TWSE:1783
Additional Paid In Capital
NT$305m
CAGR 3-Years
51%
CAGR 5-Years
28%
CAGR 10-Years
5%
G
Grape King Bio Ltd
TWSE:1707
Additional Paid In Capital
NT$2.9B
CAGR 3-Years
0%
CAGR 5-Years
24%
CAGR 10-Years
93%
Maywufa Co Ltd
TWSE:1731
Additional Paid In Capital
NT$189.4m
CAGR 3-Years
1%
CAGR 5-Years
2%
CAGR 10-Years
0%
Chlitina Holding Ltd
TWSE:4137
Additional Paid In Capital
NT$1.8B
CAGR 3-Years
10%
CAGR 5-Years
6%
CAGR 10-Years
3%

See Also

What is Maxigen Biotech Inc's Additional Paid In Capital?
Additional Paid In Capital
305m TWD

Based on the financial report for Jun 30, 2024, Maxigen Biotech Inc's Additional Paid In Capital amounts to 305m TWD.

What is Maxigen Biotech Inc's Additional Paid In Capital growth rate?
Additional Paid In Capital CAGR 10Y
5%

Over the last year, the Additional Paid In Capital growth was 5%. The average annual Additional Paid In Capital growth rates for Maxigen Biotech Inc have been 51% over the past three years , 28% over the past five years , and 5% over the past ten years .

Back to Top